These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 3137478)

  • 1. Effects of tryptamine mediated through 2 states of the 5-HT2 receptor in calf coronary artery.
    Frenken M; Kaumann AJ
    Naunyn Schmiedebergs Arch Pharmacol; 1988 May; 337(5):484-92. PubMed ID: 3137478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A paradox: the 5-HT2-receptor antagonist ketanserin restores the 5-HT-induced contraction depressed by methysergide in large coronary arteries of calf. Allosteric regulation of 5-HT2-receptors.
    Kaumann AJ; Frenken M
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Jan; 328(3):295-300. PubMed ID: 3157064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allosteric properties of the 5-HT2 receptor system of the rat tail artery. Ritanserin and methysergide are not competitive 5-HT2 receptor antagonists but allosteric modulators.
    Frenken M; Kaumann AJ
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Apr; 335(4):359-66. PubMed ID: 3110629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interconversion into a low active state protects vascular 5-HT2-receptors against irreversible antagonism by phenoxybenzamine.
    Frenken M; Kaumann AJ
    Naunyn Schmiedebergs Arch Pharmacol; 1987 May; 335(5):481-90. PubMed ID: 3614385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allosteric properties of 5-HT2 receptors in tracheal smooth muscle.
    Lemoine H; Kaumann AJ
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Jun; 333(2):91-7. PubMed ID: 2944004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A two-state model for the 5-HT2 receptor: effects of alpha-adrenoceptor ligands.
    Kaumann AJ
    J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S88-92. PubMed ID: 2459522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of 5-HT(1B/1D) and 5-HT2A receptors in 5-HT-induced contraction of endothelium-denuded rabbit epicardial coronary arteries.
    Ellwood AJ; Curtis MJ
    Br J Pharmacol; 1997 Nov; 122(5):875-84. PubMed ID: 9384503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Yohimbine and rauwolscine inhibit 5-hydroxytryptamine-induced contraction of large coronary arteries of calf through blockade of 5 HT2 receptors.
    Kaumann AJ
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Jun; 323(2):149-54. PubMed ID: 6136920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tryptaminergic receptors in the bovine pulmonary vasculature: effects of ketanserin.
    Ogunbiyi PO; Eyre P
    Res Commun Chem Pathol Pharmacol; 1984 Apr; 44(1):31-55. PubMed ID: 6328601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Participation of 5-HT1-like and 5-HT2A receptors in the contraction of human temporal artery by 5-hydroxytryptamine and related drugs.
    Verheggen R; Freudenthaler S; Meyer-Dulheuer F; Kaumann AJ
    Br J Pharmacol; 1996 Jan; 117(2):283-92. PubMed ID: 8789380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-Hydroxytryptamine (5-HT) contracts the guinea-pig isolated iliac artery via 5-HT1-like and 5-HT2 receptors.
    Pertz H
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Dec; 348(6):558-65. PubMed ID: 8133899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of U46619 on contractions to 5-HT, sumatriptan and methysergide in canine coronary artery and saphenous vein in vitro.
    Kemp BK; Cocks TM
    Br J Pharmacol; 1995 Oct; 116(4):2183-90. PubMed ID: 8564247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of ketanserin and its metabolite ketanserinol with 5HT2 receptors in pulmonary and coronary arteries of calf.
    Frenken M; Kaumann AJ
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Jul; 326(4):334-9. PubMed ID: 6482982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tryptamine-induced vasoconstrictor responses in rat caudal arteries are mediated predominantly via 5-hydroxytryptamine receptors.
    Bradley PB; Humphrey PP; Williams RH
    Br J Pharmacol; 1985 Apr; 84(4):919-25. PubMed ID: 3159458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of serotonin, histamine, and thromboxane A2 in platelet-induced contractions of coronary arteries and aortae from rabbits.
    Awano K; Yokoyama M; Fukuzaki H
    J Cardiovasc Pharmacol; 1989 May; 13(5):781-92. PubMed ID: 2472528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ICI 169,369 is both a competitive antagonist and an allosteric activator of the arterial 5-hydroxytryptamine2 receptor system.
    Kaumann AJ; Frenken M
    J Pharmacol Exp Ther; 1988 Jun; 245(3):1010-5. PubMed ID: 3385635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The subtype of serotonin (5-HT) receptors in the rat pulmonary artery.
    Uma S; Tuncer M; Kayaalp SO
    Arch Int Pharmacodyn Ther; 1987 Aug; 288(2):248-55. PubMed ID: 3675084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the serotonin receptors that mediate smooth muscle contraction in canine and porcine coronary artery.
    Cushing DJ; Cohen ML
    J Pharmacol Exp Ther; 1992 Jun; 261(3):856-62. PubMed ID: 1602389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential classification of vascular smooth muscle and endothelial cell 5-HT receptors by use of tryptamine analogues.
    Leff P; Martin GR; Morse JM
    Br J Pharmacol; 1987 Jun; 91(2):321-31. PubMed ID: 3607360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the response to 5-carboxamidotryptamine and serotonin in isolated human, monkey and dog coronary arteries.
    Toda N; Okamura T
    J Pharmacol Exp Ther; 1990 May; 253(2):676-82. PubMed ID: 2338652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.